IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 218 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $129 | -76.8% | 12,121 | -77.1% | 0.02% | -68.6% |
| Q1 2023 | $557 | -99.6% | 52,985 | +376.2% | 0.05% | +264.3% |
| Q2 2022 | $128,000 | -34.7% | 11,127 | -25.8% | 0.01% | -39.1% |
| Q3 2021 | $196,000 | -9.7% | 14,990 | -28.6% | 0.02% | -30.3% |
| Q2 2020 | $217,000 | -2.3% | 20,999 | -4.6% | 0.03% | -23.3% |
| Q1 2020 | $222,000 | -45.2% | 22,001 | -27.6% | 0.04% | -33.8% |
| Q4 2019 | $405,000 | +110.9% | 30,391 | +72.9% | 0.06% | +103.1% |
| Q2 2019 | $192,000 | -64.2% | 17,576 | -55.7% | 0.03% | -63.6% |
| Q1 2019 | $537,000 | +163.2% | 39,700 | +191.9% | 0.09% | +144.4% |
| Q4 2017 | $204,000 | +41.7% | 13,601 | +23.4% | 0.04% | -7.7% |
| Q2 2016 | $144,000 | – | 11,022 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |